A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Background: Two new formulations of an investigational 15-valent pneumococcal conjugate vaccine (PCV15-A and PCV15-B) were developed using 2 different protein-polysaccharide conjugation processes and evaluated in separate phase I/II studies (NCT02037984 [V114-004] and NCT02531373 [V114-005]) to asse...

Popoln opis

Bibliografske podrobnosti

Principais autores:	R. Rupp, D. Hurley, S. Grayson, J. Li, K. Nolan, R.D. McFetridge, J. Hartzel, C. Abeygunawardana, M. Winters, H. Pujar, P. Benner, L. Musey
Format:	Artigo
Jezik:	Inglês
Izdano:	Taylor & Francis Group 2019-03-01
Serija:	Human Vaccines & Immunotherapeutics
Teme:	pneumococcal conjugate vaccine safety immunogenicity
Online dostop:	http://dx.doi.org/10.1080/21645515.2019.1568159
Oznake:	Označite Brez oznak, prvi označite!